Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (7)
  • 2025 (52)
  • 2024 (41)
  • 2023 (76)
  • 2022 (85)
  • 2021 (70)
  • 2020 (15)
  • 2019 (22)
  • 2018 (15)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4210)
  • Synthetic drugs (1141)
  • Guns/Weapons (1041)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (646)
  • Guilty Plea (559)
  • Seizures (Drugs/Property) (484)
  • Overdose (327)
  • Major Law Enforcement Operation (278)
  • Diversion Division (254)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (239)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Money Laundering (218)
  • Gangs (202)
  • Outreach/Drug Prevention (189)
  • Fentanyl Awareness (167)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (69)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (41)
  • Counterfeit Pills (39)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Campaigns (14)
  • Terrorism (14)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (372)
  • Congressional Affairs (15)

Drug Name

  • Oxycodone (77)
  • Fentanyl (57)
  • Opioids (57)
  • Synthetic Opioids (24)
  • Hydromorphone (21)
  • Methamphetamine (14)
  • Benzodiazepines (13)
  • Morphine (11)
  • Amphetamines (9)
  • Cocaine (9)
  • Heroin (8)
  • Methadone (5)
  • Marijuana (Cannabis) (3)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (35)
  • Sede (34)
  • Seattle (25)
  • New England (24)
  • Atlanta (19)
  • Miami (19)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (14)
  • Houston (13)
  • San Francisco (13)
  • Louisville (12)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
Clear All Results
386 Results - Showing 361 to 370
PRESS RELEASE

DEA New England Field Division collects over 44 tons of prescription drugs during the 17th National Prescription Drug Take Back Day

BOSTON – The final tally is in from the 17 th National Prescription Drug Take Back Day on April 27, 2019. The United States Drug Enforcement Administration’s New England Field Division and its partners, over the course of four hours, collected 89,366 pounds or over 44 tons of expired, unused...
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day on April 27

EL PASO, Texas – With robust public participation over the course of 16 prior events, the National Prescription Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medicines from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and...
PRESS RELEASE

DEA agents serve warrants at pain management clinic and arrest naturopathic medical doctor

PHOENIX – The Drug Enforcement Administration Phoenix Field Division, along with the Arizona Attorney General’s Office, announce the arrest of naturopathic medical doctor Jelina Ip and her mother, Alane Ip, following the execution of state-authorized warrants yesterday morning in Tempe. The Ips were owners and operators of Ava Pain Management...
PRESS RELEASE

Former pharmacist sentenced for prescription fraud

BUFFALO, N.Y. – U.S. Attorney James P. Kennedy, Jr., and DEA New York Division Special Agent in Charge Ray Donovan announced today that Patrick R. McQuade, 29, of North Tonawanda, N.Y., who was convicted of obtaining controlled substances through fraud, was sentenced to two years’ probation and ordered to pay...
PRESS RELEASE

CVS to pay $535,000 for filling invalid prescriptions

PROVIDENCE, R.I. - Pharmacy chain CVS Pharmacy, Inc., has agreed to pay $535,000 to resolve the United States’ allegations that several of its Rhode Island stores violated the federal Controlled Substances Act by filling invalid prescriptions, announced DEA New England Division Special Agent in Charge Brian D. Boyle and United...
PRESS RELEASE

Fentanyl and heroin darknet vendors indicted

SACRAMENTO, Calif. — A Rancho Cordova woman was indicted on April 4, 2019, charged with distribution of fentanyl and oxycodone and other opioids as a result of a coordinated operation by the U.S. Attorney’s Office, the Federal Bureau of Investigation, Homeland Security Investigations, the Drug Enforcement Administration and the U.S...
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...
PRESS RELEASE

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...
PRESS RELEASE

Former owner of Chicago medical clinic guilty of selling opioid prescriptions to patients who lacked medical need for the drugs

CHICAGO - The former owner of a Chicago medical clinic admitted in federal court today that he sold opioid prescriptions to patients whom he knew lacked a legitimate medical need for the drugs. MOHAMMED SHARIFF, who owned Midtown Medical Center in Chicago’s Uptown neighborhood, conspired with a physician to sell...
PRESS RELEASE

DEA releases 2018 National Drug Threat Assessment

WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...

Paginación

  • Primera página «
  • Anterior
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Current page 37
  • Page 38
  • Page 39
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster